TAO Synergies (TAOX) Shares Outstanding (Diluted) (2020 - 2026)
Powered by 
Analysis
TAO Synergies (TAOX) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.88 Bn | 197.89 Bn | 7.24 Bn | 544.00 Mn |
| 2 | Gilead Sciences | 181.55 Bn | 178.37 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 132.31 Bn | 124.45 Bn | 2.84 Bn | 255.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn | 106.00 Mn |
| 5 | Argenx Se | 61.54 Bn | 56.36 Bn | 1.37 Bn | 66.03 Mn |
| 6 | Moderna | 54.69 Bn | 49.55 Bn | 52.00 Mn | 398.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.07 Bn | 30.76 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Biogen | 31.41 Bn | 30.12 Bn | 1.96 Bn | 148.70 Mn |
| 9 | Roivant Sciences | 30.10 Bn | 30.10 Bn | 1.16 Mn | 720.78 Mn |
| 10 | TAO Synergies | 30.93 Mn | 30.93 Mn | - | 7.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.47 Mn |
| Mar 31, 2026 | 7.70 Mn |
| Dec 31, 2025 | 3.30 Mn |
| Sep 30, 2025 | 2.55 Mn |
| Jun 30, 2025 | 1.57 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 11.65 Mn |
| Sep 30, 2023 | 10.70 Mn |
| Jun 30, 2023 | 7.36 Mn |
| Mar 31, 2023 | 7.50 Mn |
| Dec 31, 2022 | 6.99 Mn |
| Sep 30, 2022 | 6.99 Mn |
| Jun 30, 2022 | 6.96 Mn |
| Mar 31, 2022 | 6.94 Mn |
| Dec 31, 2021 | 5.02 Mn |
| Sep 30, 2021 | 6.20 Mn |